Eusebi Manolache

CNCAV: Almost 19,000 persons immunised in past 24 hrs, of whom half with first dose

In the past 24 hours, 18,997 doses of vaccine were administered, of which 12,867 - Pfizer, 5,151 - Johnson & Johnson, 583 - Moderna and 369 - AstraZeneca, according to a report sent by the National Coordinating Committee on Vaccination Activities (CNCAV) against COVID-19. According to CNCAV, in the same period, 9,672 people were vaccinated with the first dose and 9,325 with the second.

GCS: 31 new cases of infection with SARS-CoV-2; in nearly 26,000 tests performed in last 24 hours

A number of 31 new cases of people infected with SARS-CoV-2 have been registered in the last 24 hours, following almost 26,000 tests nationwide, the The Strategic Communication Group (GCS) informed on Thursday. These are cases of patients that have not previously tested positive.

CNCAV: 28,000 persons immunised in the past 24 hrs, less than half with first dose

Bucharest, June 30 /Agerpres/ - In the past 24 hours, 20,800 doses of vaccine were administered, of which 14,362 - Pfizer, 5,152 - Johnson & Johnson, 744 - Moderna and 542 - AstraZeneca, according to a report sent by the National Coordinating Committee on Vaccination Activities against COVID-19.

Romania's SARS-CoV-2 daily case count rises by 52; tests performed in last 24 hours: over 26,000

As many as 52 new cases of people infected with SARS-CoV-2 in Romania were recorded in the last 24 hours following over 26,000 tests nationwide, the Strategic Communication Group (GCS), the official novel coronavirus communication task force, reported on Wednesday. These are cases of patients that have not previously tested positive.

GCS: 73 new cases of infection with SARS-CoV-2; in over 29,000 tests in last 24 hours

A number of 73 new cases of infection with SARS-CoV-2 were registered in the last 24 hours, in over 29,000 tests performed, the Strategic Communication Group (GCS) announced on Tuesday. These are cases that have not previously tested positive.

Romania's COVID-19 case count up by 37 on 10,000-plus tests run in past 24 hours

Romania's SARS-CoV-2 caseload increased by 37 in the last 24 hours following more than 10,000 tests performed nationwide, the Strategic Communication Group (GCS) reports on Monday. These are all cases that have not previously had a positive test, the GCS states. As of Monday there were 1,080,667 cases of novel coronavirus infection confirmed in Romania, of which 1,045,351 were declared cured.

GCS: 92 patients with COVID-19 in ICU; hospitalized persons - 522

Bucharest, June 27 /Agerpres/ - A number of 522 people infected with the new coronavirus are hospitalized in the specialized health units, out of whom 92 in intensive care, the Strategic Communication Group (GCS) announced on Sunday. In total, 1,888 people confirmed with SARS-CoV-2 infection are in isolation at home and 837 are in institutionalized isolation in Romania, GCS said.

INSP: First death with Delta variant of novel coronavirus, recorded in Romania

The National Institute of Public Health (INSP) reported on Thursday that the first death in a COVID-19 patient infected with the Indian Delta strain of the novel coronavirus was registered in Romania. According to data published by the INSP, as of June 20, 44 cases of infections with the Indian Delta variant, considered more contagious and virulent, have been confirmed.

Romania's COVID-19 daily case count rises by 68; tests performed in last 24 hours: over 28,000

As many as 68 new cases of people infected with SARS-CoV-2 in Romania were recorded in the last 24 hours following over 28,000 tests nationwide, the Strategic Communication Group (GCS), the official novel coronavirus communication task force, reported on Thursday. These are cases of patients that have not previously tested positive.

CNCAV: 60,000 vaccine doses of Janssen (Johnson & Johnson) COVID-19 vaccine to arrive to Romania

A number of 60,000 doses of Janssen (Johnson & Johnson) COVID-19 vaccine will arrive on Thursday at the Cantacuzino National Institute for Medical-Military Research and Development in Bucharest, the National COVID-19 Vaccination Coordination Committee (CNCAV) informs.

Pages